Enhancement of Solubility of Diclofenac Sodium by Pastillation Method

Author:

Pund Sopan,Mahajan Nilesh,Gangane Purushottam,Warokar Amol

Abstract

The Diclofenac Sodium is BCS class II drug which comes under the antipyretic class drug, and has a wide range of use. But due to its low solubility it has low dissolution rate and hence reduced bioavailability. There are several methods for the enhancement of solubility and dissolution rate. Pastillation technique is widely employed in chemical industry for solidification and better handling. Pastilles are solidified discrete units, acquired directly from the melt mass. However, this method of pastillation has not been explored for the drug delivery system yet. Literature revels that it can be used as a novel, effective and easiest method for the enhancement of solubility and dissolution rate. The selection of polymer was done by the solubility studies and Kolliphor HS 15 was used to make the pastilles of Diclofenac Sodium. Formation of pastilles were confirmed by FT-IR and further evaluated for % yield, drug contents, solubility study and dissolution test. From the results it was concluded that, solubility of Diclofenac Sodium was increased by pastillation method by 2-fold and dissolution rate was also enhanced by double than that of the drug. Thus, pastillation can be an effective and easiest method to enhance the solubility, dissolution rate and bioavailability of poorly water-soluble drugs having good permeability.  Keywords: Diclofenac Sodium, Pastillation, Kolliphor HS 15, Solubility enhancement, Solid dispersion.

Publisher

Society of Pharmaceutical Tecnocrats

Subject

General Medicine

Reference6 articles.

1. 1. Yellela S. R. K., "Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs," Journal of Bioequivalence & Bioavailability. 2010; 2:28-36.

2. 2. Sharma D., Soni M., Kumar S., Gupta G.D., "Solubility enhancement-eminent role in poorly soluble drugs, Research Journal of Pharmacy and Technology. 2009; 2:220-224.

3. 3. Kumar A., Sahoo S.K., Padhee K., Kochar P.S., Sathapathy A., Pathak N., "Review on solubility enhancement techniques for hydrophobic drugs," PharmacieGlobale.2011; 3:001-007.

4. 4. Pandit. PA, Chavan TT, Khandelwal RK, Oral lipid based multipurticulat epastilles:design and effect of pore former; Journal of pharmaceutical investigation, 2015: 1-9.

5. 5. Bajrachaiya R, Sang HL et al, Development of a Ternary solid dispersion formulation of LW6 to improve the invitro activity as BCRP inhibitor: prepration and in vitro/ in vivo characterization, 2019; 1-5.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3